The Gammex 464 CT phantom better indicates the scanner's performance with a phantom that more accurately mimics a torso.  The optional Gammex 464-Ring torso adapter permits the use of the Gammex 464 Accreditation in this type of application

The American College of Cardiology announced 35 selected hospitals that are pioneering a team approach to keep patients healthy and at home following admission for heart attack or heart failure. The hospitals from across the country are the first participants in the ACC Patient Navigator Program, which is the first program of its kind in cardiology and supports national efforts to reduce unnecessary patient readmissions.

Metro Health (Michigan) cardiovascular specialist Jihad Mustapha, M.D., is one of the first physicians in the United States to use a new medical device to treat peripheral artery disease (PAD).

Cardiovascular Systems Inc. announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study. Taking place in the United States and Japan, the study is designed to assess the safety and efficacy, as well as economic outcomes, of CSI’s new micro crown Orbital Atherectomy System (OAS) in treating severely calcified coronary lesions in patients suffering from coronary artery disease (CAD). Shigeru Saito, M.D., director of cardiology and catheterization laboratories, Shonan Kamakura General Hospital, Kamakura, Japan, performed the procedures on Oct. 27.

New physician experience for the Convergent Procedure in the treatment of persistent atrial fibrillation (AF) was presented during a podium talk at the Northeast Cardiothoracic Surgical Society 20th Annual Meeting held last week in East Madison, N.H. William M. Boedefeld II, M.D., of CVT Surgical Center in Baton Rouge, La., reported on 224 patients, 66 percent of whom had persistent or longstanding persistent AF and 34 percent who had paroxysmal AF. At one-year follow-up, 93 percent of patients were in sinus rhythm.

Subscribe Now